NCT02711657View on ClinicalTrials.gov

Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

April 30, 2017

Conditions
Interstitial Lung DiseasesRheumatoid ArthritisAsthma
Interventions
OTHER

Fibrocyte measurement and lung function test.

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT02711657 - Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease. | Biotech Hunter | Biotech Hunter